Why Seelos Therapeutics' Stock Is Trading Higher Today

Seelos Therapeutics SEEL shares are trading higher. Traders are circulating a Massachusetts General Hospital report titled 'Investigational drug SLS-005 (Trehalose) receives "May Proceed" notice and Central IRB approval for the HEALEY ALS Platform Trial.'

Seelos Therapeutics' stock is trading up 23.58% to a price of $2.35. Tuesday the stock has been traded at a volume of 18.90 million, about 1029.43% of its recent 30-day volume average of 1.84 million.

The 50-day moving average price of Seelos Therapeutics's stock was $2.17 when this article was published. The stock reached a high of $6.6 and a low of $0.56 in the past 52 weeks.

If you're looking for timely and concise explanations of why a stock is moving, check out Benzinga Pro. Subscribers get ‘Why Is It Moving' alerts as soon as our research team identifies the cause of the price action in a stock. Click here to learn more.

Market News and Data brought to you by Benzinga APIs
Posted In: NewsBZI-WIIM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!